D

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Watchlist Manager
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Watchlist
Price: 188 IDR 0.53% Market Closed
Market Cap: 235B IDR

Intrinsic Value

The intrinsic value of one DGNS stock under the Base Case scenario is 319.33 IDR. Compared to the current market price of 188 IDR, Diagnos Laboratorium Utama PT Tbk is Undervalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DGNS Intrinsic Value
319.33 IDR
Undervaluation 41%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation History
Diagnos Laboratorium Utama PT Tbk

What is Valuation History?
Ask AI Assistant
What other research platforms think about DGNS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DGNS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Diagnos Laboratorium Utama PT Tbk.

Explain Valuation
Compare DGNS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about DGNS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Diagnos Laboratorium Utama PT Tbk

Current Assets 85.5B
Cash & Short-Term Investments 4.5B
Receivables 55.3B
Other Current Assets 25.7B
Non-Current Assets 220.2B
Long-Term Investments 13B
PP&E 202.1B
Intangibles 1.6B
Other Non-Current Assets 3.6B
Current Liabilities 24.7B
Accounts Payable 8.7B
Accrued Liabilities 4.2B
Other Current Liabilities 11.8B
Non-Current Liabilities 87.5B
Long-Term Debt 78.9B
Other Non-Current Liabilities 8.5B
Efficiency

Free Cash Flow Analysis
Diagnos Laboratorium Utama PT Tbk

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Diagnos Laboratorium Utama PT Tbk

Revenue
281.3B IDR
Cost of Revenue
-155.2B IDR
Gross Profit
126.1B IDR
Operating Expenses
-126.2B IDR
Operating Income
-71.6m IDR
Other Expenses
-1.8B IDR
Net Income
-1.9B IDR
Fundamental Scores

DGNS Profitability Score
Profitability Due Diligence

Diagnos Laboratorium Utama PT Tbk's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
39/100
Profitability
Score

Diagnos Laboratorium Utama PT Tbk's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

DGNS Solvency Score
Solvency Due Diligence

Diagnos Laboratorium Utama PT Tbk's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Average Altman Z-Score
47/100
Solvency
Score

Diagnos Laboratorium Utama PT Tbk's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DGNS Price Targets Summary
Diagnos Laboratorium Utama PT Tbk

There are no price targets for DGNS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DGNS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one DGNS stock?

The intrinsic value of one DGNS stock under the Base Case scenario is 319.33 IDR.

Is DGNS stock undervalued or overvalued?

Compared to the current market price of 188 IDR, Diagnos Laboratorium Utama PT Tbk is Undervalued by 41%.

Back to Top